Unimolecular Photodynamic O₂-Economizer To Overcome Hypoxia Resistance in Phototherapeutics

Abstract

Tumor hypoxia has proven to be the major bottleneck of photodynamic therapy (PDT) to clinical transformation. Different from traditional O2 delivery approaches, here we describe an innovative binary photodynamic O2-economizer (PDOE) tactic to reverse hypoxia-driven resistance by designing a superoxide radical (O2 •–) generator targeting mitochondria respiration, termed SORgenTAM. This PDOE system is able to block intracellular O2 consumption and down-regulate HIF-1α expression, which successfully rescues cancer cells from becoming hypoxic and relieves the intrinsic hypoxia burden of tumors in vivo, thereby sparing sufficient endogenous O2 for the PDT process. Photosensitization mechanism studies demonstrate that SORgenTAM has an ideal intersystem crossing rate and triplet excited state lifetime for generating O2 •– through type-I photochemistry, and the generated O2 •– can further trigger a biocascade to reduce the PDT’s demand for O2 in an O2-recycble manner. Furthermore, SORgenTAM also serves to activate the AMPK metabolism signaling pathway to inhibit cell repair and promote cell death. Consequently, using this two-step O2-economical strategy, under relatively low light dose irradiation, excellent therapeutic responses toward hypoxic tumors are achieved. This study offers a conceptual while practical paradigm for overcoming the pitfalls of phototherapeutics.

A pH‐Responsive Polymer‐CeO2 Hybrid to Catalytically Generate Oxidative Stress for Tumor Therapy

“…Nevertheless, the relatively deficient intratumoral H 2 O 2 level significantly lowers the biocatalytic therapeutic efficiency. [ 21–27 ]…”

Recent Advances in Activatable Organic Photosensitizers for Specific Photodynamic Therapy

“…[51] Suppression of the OXPHOS by inhibitors such as atovaquone and tamoxifen has been recently demonstrated as an efficient method in sparing physiological O 2 to reverse the tumor hypoxia. [52] It could be thus anticipated that the integration of activatable PSs with OXPHOS inhibitors via covalently conjugation or nano-assembly should produce a novel type of O 2 -economized activatable PSs. In addition, due to low O 2 -dependence, the development of activatable type-I PSs is highly encouraged to address the hypoxia dilemmas of PDT.…”

A photo-sensitizable phage for multidrug-resistant Acinetobacter baumannii therapy and biofilm ablation

“…Nile blue dyes (NB) are cationic photosensitizers and their excellent photodynamic effect has been previously validated. [18][19][20] Structural modication with a "sulfur atom" can effectively improve the triplet yield, thus improving the sensitivity of PACT. Furthermore, bacteriophages have demonstrated particular specicity to their hosts.…”